November, 08 2026 Sunday 15:57 Hrs
Last update 11-9-2025
  • SENSEX :   80,999.40

  • Top commodity trading and broking companies in India-28.62( -0.04%) 08-Nov-2026
Negative
Sensex 80999.4 -28.62  (-0.04) 08-Nov-2026
Previous Day Close 81028.02
Today's High/Low
High Low
  •  
  •  
81442.11 80932.42

Company News Details

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
97.3802066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
127.84
446276.3
EPS(TTM)
Face Value()
Div & Yield %
14.55
1
0.86
 

sun pharmaceuticals industries ltd
Sun Pharma receives USFDA approval for ILUMYA® (tildrakizumab-asmn)
Oct 30,2026

Sun Pharmaceutical Industries announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

'FDA approval of ILUMYA for adults with active psoriatic arthritis represents another important innovative medicine milestone for Sun Pharma and builds on the established clinical experience of ILUMYA in plaque psoriasis,” said Rick Ascroft, North America CEO, Sun Pharma. 'As an IL-23 inhibitor administered exclusively by a healthcare provider, ILUMYA is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment or who may benefit from regular in-office care.'

Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.